ACE Inhibition in secondary prevention: are the results controversial?

  title={ACE Inhibition in secondary prevention: are the results controversial?},
  author={Dr. med. Erik B. Friedrich and Koon Kang Teo and Michael B{\"o}hm},
  journal={Clinical Research in Cardiology},
Results from the HOPE and EUROPA trials showed that ACE inhibitors lower cardiovascular mortality of patients with atherosclerosis and preserved left ventricular function. However, despite apparently adequate study design, the recently conducted PEACE trial detected no benefit of an additional ACE inhibitor treatment in patients with coronary artery disease and no heart failure with respect to cardiovascular risk reduction. One of the main reasons for this discrepancy might be the lower… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 15 extracted citations


Publications referenced by this paper.
Showing 1-10 of 13 references

ACE inhibition in stable coronary artery disease.

The New England journal of medicine • 2005
View 4 Excerpts
Highly Influenced

Deaths : leading causes for 2001

S Yusuf
Natl Vital Stat Rep • 2005

Deaths: leading causes for 2001.

National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System • 2003
View 1 Excerpt

fects of an angiotensin - converting - enzyme inhibitor , ramipril , on cardiovascular events in high - risk patients

KM Fox
N Engl J Med • 2000

Angiotensin - converting - enzyme inhibition in stable coronary artery disease

GB Mancini, GC Henry, C Macaya
N Engl J Med • 1996

Similar Papers

Loading similar papers…